PT  - JOURNAL ARTICLE
AU  - Andrew M. Youssef
AU  - Ke Peng
AU  - Pearl Kijoo Kim
AU  - Alyssa Lebel
AU  - Navil F. Sethna
AU  - Corey Kronman
AU  - David Zurakowski
AU  - David Borsook
AU  - Laura E. Simons
TI  - Pain Stickiness in Complex Regional Pain Syndrome: A role for the Nucleus Accumbens
AID  - 10.1101/769802
DP  - 2019 Jan 01
TA  - bioRxiv
PG  - 769802
4099  - http://biorxiv.org/content/early/2019/09/17/769802.short
4100  - http://biorxiv.org/content/early/2019/09/17/769802.full
AB  - Some individuals with chronic pain experience improvement in their pain with treatment, whereas others do not. The neurobiological reason is unclear, but an understanding of brain structure and functional patterns may provide insights into pain’s responsivity to treatment. In this investigation, we used magnetic resonance imaging (MRI) techniques to determine grey matter density alterations on resting functional connectivity (RFC) strengths between pain responders and nonresponders. Brain metrics of pediatric patients at admission to an intensive pain rehabilitative treatment program were evaluated. Pain responders reported significant pain improvement at discharge and/or follow-up whereas nonresponders reported no improvements, increases in pain, or emergence of new pain symptoms. The pain (responder/nonresponder) groups were compared with pain-free healthy controls to examine predictors of pain responder status via brain metrics. Our results show: (1) on admission, pain nonresponders had decreased grey matter density (GMD) within the nucleus accumbens (NAc) and reduced RFC strength between the NAc and the dorsolateral prefrontal cortex vs. responders; (2) Connectivity strength was positively correlated with change in pain intensity from admission to discharge; (3) Compared with pain-free controls, grey matter and RFC differences emerged only among pain nonresponders; and (4) Using a discriminative model, combining GMD and RFC strengths assessed at admission showed the highest prediction estimate (87%) on potential for pain improvement, warranting testing in a de novo sample. Taken together, these results support the idea that treatment responsiveness on pain is underpinned by concurrent brain structure and resting brain activity.